Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

No reported Selling, General & Admin figures are available to summarize.

Selling, General & Admin history

Currency unavailable · from the income statement

No Selling, General & Admin data reported for this period type.

Selling, General & Admin vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
Selling, General & Admin for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PCRXPacira BioSciences, Inc.LTM Mar 2026$375.93M USD+21.7%+13.2%51.2%
SCLXScilex Holding CompanyLTM Mar 2026$269.6M USD+128.9%+60.2%796.2%
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$206.83M USD-15.5%+17.1%26.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+21.7%+17.1%51.2%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.